BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37827132)

  • 1. Comprehensive Analysis of the Relationship between Cuproptosis-Related Gene GCSH and Prognosis, Tumor Microenvironment Infiltration, and Therapy Response in Endometrial Cancer.
    Zhao M; Nie H; Qiu P; Yu Y; Wang H; Wang F; Fang J; Zhao Q
    Oncology; 2024; 102(5):368-381. PubMed ID: 37827132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
    Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
    BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
    Nie H; Yu Y; Wang F; Huang X; Wang H; Wang J; Tao M; Ning Y; Zhou J; Zhao Q; Xu F; Fang J
    Cancer Immunol Immunother; 2024 Jun; 73(8):156. PubMed ID: 38834869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
    Nie H; Wang H; Zhang M; Ning Y; Chen X; Zhang Z; Hu X; Zhao Q; Chen P; Fang J; Wang F
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5453-5468. PubMed ID: 36462036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma.
    Shan J; Geng R; Zhang Y; Wei J; Liu J; Bai J
    Comput Biol Med; 2022 Oct; 149():105988. PubMed ID: 36007289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses.
    He R; Li Y; Jiao P; Huang Y; Dong S; Mo L; Jiao X
    J Cancer; 2024; 15(6):1551-1567. PubMed ID: 38370386
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
    Li W; Zhang X; Chen Y; Pang D
    Front Oncol; 2022; 12():966511. PubMed ID: 36212436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancer: A field synopsis of observational study.
    Li W; Qin Y; Chen X; Wang X
    Medicine (Baltimore); 2023 Jun; 102(25):e34047. PubMed ID: 37352078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer.
    Wang G; Wang D; Sun M; Liu X; Yang Q
    Int Immunopharmacol; 2020 Nov; 88():106931. PubMed ID: 32889237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a seven cuproptosis-associated lncRNA signature to predict the prognosis of endometrial cancer.
    Cai L; Cai L; Zhou L; Zhao Y; Qian J
    J Int Med Res; 2023 Dec; 51(12):3000605231213435. PubMed ID: 38102991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
    Cheng P; Ma J; Zheng X; Zhou C; Chen X
    Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
    Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
    Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder.
    Feng H; Deng Z; Huang Y; Liu Z; Ruan Y; Wang T; Liu J
    Front Immunol; 2023; 14():1219209. PubMed ID: 37662947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X; Ye Z; Xiao G; He T
    Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
    Chen X; Hu G; Xiong L; Xu Q
    Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.